Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 5.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 1.93 | - |
NAV | ₹433.77 | - |
Fund Started | 04 Jun 1999 | - |
Fund Size | ₹4026.55 Cr | - |
Exit Load | Exit load of 0.50% if redeemed within 15 days | - |
Risk
Very High
-
Rating
5.0
-
Min SIP Amount
₹500
-
Expense Ratio
1.93
-
NAV
₹433.77
-
Fund Started
04 Jun 1999
-
Fund Size
₹4026.55 Cr
-
Exit Load
Exit load of 0.50% if redeemed within 15 days
-
Returns
1 Year | 10.79% | - |
3 Year | 26.58% | - |
5 Year | 20.29% | - |
1 Year
10.79%
-
3 Year
26.58%
-
5 Year
20.29%
-
Holding Analysis
Equity | 97.60% | - |
Cash | 2.33% | - |
Equity
97.60%
-
Cash
2.33%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.44% |
Divi's Laboratories Ltd. | 7.21% |
Max Healthcare Institute Ltd. | 6.50% |
Cipla Ltd. | 4.63% |
Lonza Group Ag | 4.09% |
Lupin Ltd. | 4.02% |
Gland Pharma Ltd. | 3.59% |
Mankind Pharma Ltd. | 3.57% |
Acutaas Chemicals Ltd. | 3.30% |
Krishna Institute of Medical Sciences Ltd | 3.26% |
-
Fund Manager
Name | Tanmaya Desai | - |
Start Date | 27 Jun 2011 | - |
Name
Tanmaya Desai
-
Start Date
27 Jun 2011
-
About Fund
Description | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. | - |
Launch Date | 04 Jun 1999 | - |
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
-
Launch Date
04 Jun 1999
-
